A feasible femoral cannulation method during cardiopulmonary bypass.
Satta
J
J
Rimpiläinen
J
J
Rainio
P
P
Juvonen
T
T
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation; D002315:Cardiopulmonary Bypass / Q000295:instrumentation / Q000379:methods*; D002406:Catheterization, Peripheral / Q000295:instrumentation*; D005240:Feasibility Studies; D005263:Femoral Artery / Q000601:surgery*; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000517:prevention & control; D007866:Leg / Q000098:blood supply; D011093:Polyethylene Terephthalates; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D013499:Surface Properties
D000925:Anticoagulants; D011093:Polyethylene Terephthalates; D011138:Polytetrafluoroethylene; D006493:Heparin